11/18/2026 | Press release | Distributed by Public on 11/18/2026 09:24
HCA HealthONE Presbyterian St. Luke's is advancing blood cancer care as the first and only hospital in Colorado to offer total marrow and lymphoid irradiation (TMLI), an innovative radiation treatment for patients undergoing allogeneic stem cell transplantation. The hospital successfully treated its first patient on November 2, 2026, joining a select group of specialized transplant centers nationwide offering this advanced therapy.
TMLI uses highly precise radiation technology to target the bone marrow and lymphatic system while significantly reducing radiation exposure to healthy organs, including the heart, lungs and kidneys. Unlike traditional total body irradiation, this targeted approach may allow physicians to deliver higher radiation doses to targeted tissues while minimizing exposure to surrounding healthy organs. This creates promising treatment opportunities for select patients with high-risk, relapsed or treatment-resistant blood cancers.
The introduction of TMLI was made possible through a collaborative effort between the HCA HealthONE Presbyterian St. Luke's, Colorado Blood Cancer Institute and Kaiser Permanente physicians and clinical teams. Together, the teams worked to bring this highly specialized treatment to patients, combining expertise in radiation oncology, stem cell transplantation and medical physics.
"This is an exciting milestone for blood cancer care in Colorado," said Tara Gregory, MD, Group President of Colorado Blood Cancer Institute. "TMLI gives us another advanced treatment option for patients facing aggressive blood cancers. Through our partnership with Dr. Wojcieszynski and the Radiation Oncology team, we're able to bring this innovative therapy to patients right here in Colorado, helping them receive highly specialized care closer to home."
"What makes TMLI so promising is the ability to deliver radiation with extraordinary precision, targeting the areas where treatment is needed, reducing exposure to healthy organs, and bringing treatment to more patients" said Andrzej Wojcieszynski, MD, radiation oncologist with Kaiser Permanente. "Bringing this technology to our patients required tremendous collaboration between Radiation Oncology and Colorado Blood Cancer Institute. It's rewarding to see our teams come together to make a treatment of this complexity available to patients who may benefit from it."
This milestone reinforces the shared commitment of HCA HealthONE Presbyterian St. Luke's and Colorado Blood Cancer Institute to advancing innovative cancer care and bringing highly specialized treatments to patients throughout Colorado and the Rocky Mountain region.